
Over five months, contributed to the caravagnalab/ProCESS-examples repository by developing and enhancing cancer evolution simulation workflows and validation frameworks for copy number variation analysis. Built end-to-end pipelines in R and Shell, integrating tools such as ASCAT, CNVkit, and Sequenza to enable cross-caller CNA validation, robust simulation setup, and reproducible analytics. Delivered automated reporting scripts, improved data management, and introduced configurable simulation environments with comprehensive documentation. Developed visualization scripts for mutation data and evolutionary dynamics, supporting clearer interpretation and publication readiness. The work emphasized reliability, scalability, and reproducibility, advancing cancer genomics research through rigorous computational biology and data analysis practices.
March 2026 monthly summary for caravagnalab/ProCESS-examples: Delivered SPN07 Supplementary Figures Visualization, introducing an R script to generate supplementary figures for the SPN07 study, focusing on visualizing mutation data and evolutionary dynamics in cancer samples. The visuals include pie charts for sample composition, exposure evolution, and univariate VAF distributions, enabling clearer interpretation of clonal evolution and mutation signatures. This work enhances data storytelling, reproducibility, and readiness for publication.
March 2026 monthly summary for caravagnalab/ProCESS-examples: Delivered SPN07 Supplementary Figures Visualization, introducing an R script to generate supplementary figures for the SPN07 study, focusing on visualizing mutation data and evolutionary dynamics in cancer samples. The visuals include pie charts for sample composition, exposure evolution, and univariate VAF distributions, enabling clearer interpretation of clonal evolution and mutation signatures. This work enhances data storytelling, reproducibility, and readiness for publication.
Monthly summary for 2025-07 focusing on SPN07 Mutation Simulation Enhancements in caravagnalab/ProCESS-examples. Delivered key feature enhancements to improve genetic mutation simulation accuracy, plus comprehensive documentation and configurable options. No major bugs fixed were documented for this period based on provided data.
Monthly summary for 2025-07 focusing on SPN07 Mutation Simulation Enhancements in caravagnalab/ProCESS-examples. Delivered key feature enhancements to improve genetic mutation simulation accuracy, plus comprehensive documentation and configurable options. No major bugs fixed were documented for this period based on provided data.
June 2025 monthly summary for caravagnalab/ProCESS-examples highlighting key features delivered, major validation improvements, and the resulting business impact. The month focused on strengthening CNV CNA validation and cross-caller analysis to improve reliability and reporting of CNV events across multiple callers.
June 2025 monthly summary for caravagnalab/ProCESS-examples highlighting key features delivered, major validation improvements, and the resulting business impact. The month focused on strengthening CNV CNA validation and cross-caller analysis to improve reliability and reporting of CNV events across multiple callers.
May 2025 performance summary for caravagnalab/ProCESS-examples: Delivered a major feature enhancement to the ProCESS Simulation Environment and introduced an automated tissue reports script. No major bugs were documented this month. The changes enable scalable batch executions, improved data organization, and reproducible analytics, accelerating the path from experiments to insights.
May 2025 performance summary for caravagnalab/ProCESS-examples: Delivered a major feature enhancement to the ProCESS Simulation Environment and introduced an automated tissue reports script. No major bugs were documented this month. The changes enable scalable batch executions, improved data organization, and reproducible analytics, accelerating the path from experiments to insights.
April 2025: Focused on delivering end-to-end CNA validation and SPN07 cancer evolution enhancements. Key outcomes include expanded SPN07 simulation setup (CNA validation, increased batch resources, mutation-driven design, multiple-clone modeling, data file additions, and phylogenetic-tree generation) and the development of a CNA call validation framework across ASCAT and rRACES with parsing, comparison, and visualization. These efforts improve cross-pipeline accuracy, reproducibility, and business-value by enabling reliable CNA detection, robust simulation experimentation, and scalable batch workflows. Technologies leveraged include R for multi-clone modeling, scripting for batch jobs, data management, and cross-tool visualization.
April 2025: Focused on delivering end-to-end CNA validation and SPN07 cancer evolution enhancements. Key outcomes include expanded SPN07 simulation setup (CNA validation, increased batch resources, mutation-driven design, multiple-clone modeling, data file additions, and phylogenetic-tree generation) and the development of a CNA call validation framework across ASCAT and rRACES with parsing, comparison, and visualization. These efforts improve cross-pipeline accuracy, reproducibility, and business-value by enabling reliable CNA detection, robust simulation experimentation, and scalable batch workflows. Technologies leveraged include R for multi-clone modeling, scripting for batch jobs, data management, and cross-tool visualization.

Overview of all repositories you've contributed to across your timeline